Funding for Faculty

Siteman Funding Opportunities Newsletter

Download the latest Siteman Funding Opportunities Newsletter (PDF)

The newsletter and the list of open opportunities on this page are not fully inclusive of all available cancer-related funding. Please be sure to consult other sources to learn of other opportunities not listed here.

Rolling Deadlines: Internal Grant Resources (≤$25K)

SBSR Grant Support – Siteman Biostatistics Shared Resource

Additional Details

RFP Snapshot: The Siteman Biostatistics Shared Resource provides advice and support to PIs in preparation of grant applications.

Max Amount and Period: N/A

Eligibility: Must be Siteman Cancer Center members.

Due Date: Rolling

WUSTL CDC Match Grants – WUSTL Center for Drug Discovery

Additional Details

RFP Snapshot: The WUSTL CDC has various match funding programs as follows:

  • CDD Match Grant15
  • CDD Match Grant25

Max Amount and Period: Varies

Eligibility: Varies

Due Date: Rolling

WUSM ICTS Innovation Awards – Institute of Clinical and Translational Sciences

Additional Details

RFP Snapshot: The purpose of these Precision Health Innovation awards is to advance initial discovery pilots for Precision Health ICTS investigators. Proposals are not for developed projects but are to fund developmental or early stage work, including pilot data collection and analysis, in preparation for submission of future external funding.

Max Amount and Period: $25,000 for 1 year

Eligibility: Applicants must be full time faculty at WUSTL or an ICTS partner institution and must be a member of the ICTS.

Due Date: Rolling

 

 

WUSM ICTS Just-in-Time (JIT) Core Usage Funding Program – Institute of Clinical and Translational Sciences and Siteman Cancer Center

Additional Details

RFP Snapshot: The Just-In-Time (JIT) Core Usage Funding Program is designed to provide quick access to funding to use any of the JIT Cores (pdf) for research advancing medical knowledge that can improve human health. The Siteman Cancer Center will co-sponsor cancer-focuses proposals.

Max Amount and Period: Varies

Eligibility: Applicant must be a registered member of the ICTS and hold a faculty level appointment at WUSTL or an ICTS partner institution.

Due Date: Rolling

February Deadlines

February 3: OutSmarting Osteosarcoma Research Award – MIB (Make It Better) Agents

Additional Details

RFP Snapshot: MIB Agents’ funding priorities are a) late stage translational research leading to a trial in 1 to 3 years, b) studies with promising preclinical data that have a specific funding need to move to a clinical trial, and c) specific funding gaps in clinical research.

Max Amount and Period: $100,000 for 1 year

Eligibility: Applicant must be an independent investigator with experience in translational research at the rank of Assistant Professor, Associate Professor, Full Professor, and Research Scientists with a MD, DO, DVM, and/or PhD. Applicants must be legal US residents engaged by an institution located in the US for the duration of the grant period.

Due Date: February 3, 2023 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

February 3: OutSmarting Osteosarcoma Young Investigator Research Award – MIB (Make It Better) Agents

Additional Details

RFP Snapshot: MIB Agents’ funding priorities are a) late stage translational research leading to a trial in 1 to 3 years, b) studies with promising preclinical data that have a specific funding need to move to a clinical trial, and c) specific funding gaps in clinical research.

Max Amount and Period: $50,000 for 1 year

Eligibility: Applicants must have a MD, DO, DVM, and/or PhD and be within 5 years of their fellowship with experience in translational research. Their academic rank must be at Assistant Professor or lower. At the time of application and award, the applicant must not hold an NIH R or P award. A research mentor must be identifed at the time of application. Applicants must be legal US residents engaged by an institution located in the US for the duration of the grant period.

Due Date: February 3, 2023 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

February 5: Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) – NIH/NCI

Additional Details

RFP Snapshot: This opportunity encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities. These research project grants (R01) will support innovative studies designed to investigate biological/genetic bases of cancer health disparities.

Max Amount and Period: Budgets are not limited, but must reflect the actual needs of the project. 5 year project period.

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support.

Due Date: February 5, 2023 at 5PM CST

Application Assistance: Washington University faculty may reach out to Sarah Van Vickle-Chavez in Public Health Sciences at sarahv@wustl.edu with any questions and for assistance with the proposal, including gathering pertinent catchment statistics.

February 10: LOI: PCF Young Investigator Award – Prostate Cancer Foundation

Additional Details

RFP Snapshot: Research proposals submitted in consideration for this award should, if successful, provide high impact to the field. “Small-step” or incremental proposals are usually non-competitive. Highly innovative basic science programs will be carefully considered, but priority will be given to “bench to bedside” translational research proposals with the potential to deliver near term benefit to patients.

Max Amount and Period: $225,000 over 3 years

Eligibility: Applicants must hold the title of Postdoctoral Fellow, Instructor, Research Associate, Assistant Professor and be within six-years of their degree completion. They must be under the direct supervision of at least one mentor. The applicant should not have been granted commitments for more than $300,000 in direct research funding from all sources. VA Career Development Awardees are eligible to apply for this award provided they have completed at least 3 years of the Career Development Award by the time of application submission to PCF. Applicants traditionally under-represented in science and medicine are highly encouraged. Applicants may be working in basic, translational, computational or clinical research and need not be trained specifically in prostate cancer research to be highly competitive.

Due Date: Letter of Intent Due: February 10, 2023 at 2PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

February 13: Career Development Award to Promote Diversity and Inclusion in Breast Cancer Research – AACR-Breast Cancer Research Foundation

Additional Details

RFP Snapshot: The Breast Cancer Research Foundation-AACR Career Development Awards to Promote Diversity and Inclusion represent a focused effort to encourage and support investigators from diverse backgrounds that are underrepresented in cancer research and to foster their career advancement. This grants program also intends to build a more diverse and inclusive future for breast cancer research. Eligibility is limited to members of racial or ethnic groups that have been shown to be traditionally excluded in the cancer related sciences workforce. Selection is competitive and will be based on outstanding accomplishments both in scientific research and in promoting diversity, equity, and inclusion within the cancer research community. Proposed projects must be basic, translational, clinical, epidemiological, population health, and/or community-based cancer research projects designed to accelerate the discovery, development, and application of new agents to treat breast cancer. Research that aims to advance the science of understanding cancer health disparities in racial and ethnic minorities that has relevance to breast cancer will also be considered.

Max Amount and Period: $150,000 over 2 years

Eligibility: Applicants must hold a faculty position with the title of Instructor, Assistant Professor, Research Assistant Professor and belong to a racial or ethnic group that has been shown to be traditionally excluded in the cancer related sciences workforce.

Due Date: February 13, 2023 at Noon CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

February 15: ACPMP Research Foundation Catalyst Research Grant – Appendix Cancer Pseudomyxoma Peritonei Research Foundation

Additional Details

RFP Snapshot: The ACPMP Research Foundation Catalyst Research Grant Program is intended to support basic scientific, clinical, or translational research that is focused on appendix cancer and/or appendiceal pseudomyxoma peritonei (PMP). The aim of this grant program is to promote studies of the biology, epidemiology, genetics, pharmacology, immunobiology, or biochemistry of malignant epithelial neoplasms of the appendix that have the potential to yield diagnostic, therapeutic, or population-based advances for these rare cancers. These studies may focus on appendiceal mucinous neoplasms, appendiceal adenocarcinomas (including signet ring cell adenocarcinoma and goblet cell adenocarcinoma), and/or pseudomyxoma peritonei of appendiceal origin.

Max Amount and Period: $50,000 over 2 years

Eligibility: Applicants must have a doctoral degree (e.g., MD, Ph.D, MD/Ph.D) in a related field and employment at a medical, academic or research institution. Full-time faculty members with an appointment at the rank of Assistant Professor or above are permitted to submit one proposal per application cycle.

Due Date: February 15, 2023 at 4PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

February 16: Basic Research in Cancer Health Disparities (R03 Clinical Trial Not Allowed) – NIH/NCI

Additional Details

RFP Snapshot: This opportunity encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities. These small research grants (R03) will support projects on cancer health disparities that can be carried out in a short period of time with limited resources.

Max Amount and Period: $100,000 over 2 years

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support.

Due Date: February 16, 2023 at 5PM CST

Application Assistance: Washington University faculty may reach out to Sarah Van Vickle-Chavez in Public Health Sciences at sarahv@wustl.edu with any questions and for assistance with the proposal, including gathering pertinent catchment statistics.

February 16: Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) – NIH/NCI

Additional Details

RFP Snapshot: This Funding Opportunity Announcement (FOA) encourages grant applications from investigators interested in conducting basic research studies into the biological/genetic causes and mechanisms of cancer health disparities. These awards will support pilot and feasibility studies designed to investigate biological/genetic bases of cancer health disparities.

Max Amount and Period: $275,000 over 2 years

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support.

Due Date: February 16, 2023 at 5PM CST

Application Assistance: Washington University faculty may reach out to Sarah Van Vickle-Chavez in Public Health Sciences at sarahv@wustl.edu with any questions and for assistance with the proposal, including gathering pertinent catchment statistics.

February 16: LOI: Seed Grants for Interdisciplinary Research – WUSTL Office of the Vice Chancellor of Research (OVCR)

Additional Details

RFP Snapshot: This opportunity provides funds to support interdisciplinary teams (collaboration from at least two schools within WU) with new and innovative research that has potential for broad scientific or societal impact. Seed grants will address complex transformative problems that require an interdisciplinary approach; are currently not funded; and have a future potential for increased funding, either through the federal government or through substantial foundation or philanthropic support. These funds can be used to gather pilot data with a goal of successfully competing for future sponsored research opportunities.

Max Amount and Period: $50,000 for 1 year

Eligibility: Applicants must be full-time faculty at Washington University at the time of application. Each application must have tangible collaboration from at least two schools within Washington University (i.e. A minimum of two Co-PIs required with primary appointment in different schools. If there are three Co-PIs on the application, at least two schools must be represented by the Co-PIs primary appointments).

Due Date: Letter of Intent Due: February 16, 2023 at 11:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

February 17: LOI: Translation to CURE Award (T2C) – CURE Childhood Cancer

Additional Details

RFP Snapshot: The goal of this award is to fund investigators from the Assistant Professor to Full Professor career stages in their pediatric cancer projects. Priority will be given to projects with anticipated clinical testing or application within the next 2-3 years. Examples of research areas include: high risk ALL or relapse ALL, acute myeloid leukemia, neuroblastoma at stage 4, mycN amplified neuroblastoma, wilms tumor anaplastic stage IV or relapse disease, metastatic sarcomas (e.g., bone and soft tissue, osteosarcoma), or pediatric brain tumors, high risk.

Max Amount and Period: $300,000 over 2 years

Eligibility: Applicants must be at the level of Assistant Professor or higher. A single, Principal Investigator (PI) must be designated as fully responsible for the conduct of the project, and a PI cannot hold more than one grant at a time from CURE. CURE will accept only one application from a PI; however, this does not preclude the participation of the PI in secondary roles on other applications or grants.

Due Date: Letter of Intent Due: February 17, 2023 at 4PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

February 17: LOI: Early Investigator Award – CURE Childhood Cancer

Additional Details

RFP Snapshot: The goal of this award is to fund beginning scientists and physician scientists at the level of Instructor or Assistant Professor in their pediatric cancer projects. Priority will be given to projects with anticipated clinical testing or application within the next 2-3 years. Examples of research areas include: high risk ALL or relapse ALL, acute myeloid leukemia, neuroblastoma at stage 4, mycN amplified neuroblastoma, wilms tumor anaplastic stage IV or relapse disease, metastatic sarcomas (e.g., bone and soft tissue, osteosarcoma), or pediatric brain tumors, high risk.

Max Amount and Period: $200,000 over 2 years

Eligibility: Physician scientists (MD or MD/PhD) who are within 5 years of completion of their clinical (or terminal) fellowship training and are beginning to establish a research career may apply as Instructors or Assistant Professors. PhD scientists within 5 years of an initial appointment as a tenure track Assistant Professor are also invited to apply for this award. Eligible applicants may not have R-level funding from NIH at the time of application; however, concurrent R00 or K awards are allowed. An established research mentor is highly recommended but not required. A single, Principal Investigator (PI) must be designated as fully responsible for the conduct of the project, and a PI cannot hold more than one grant at a time from CURE. CURE will accept only one application from a PI; however, this does not preclude the participation of the PI in secondary roles on other applications or grants.

Due Date: Letter of Intent Due: February 17, 2023 at 4PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

February 20: CTF Drug Discovery Initiative – Children’s Tumor Foundation

Additional Details

RFP Snapshot: The goal of the Drug Discovery Initiative (DDI) program is to stimulate NF drug discovery by funding researchers proposing to investigate novel or repurposing therapies for NF or to develop tools to support such research. Proposals are expected to be short and concentrated on obtaining key preliminary data needed to quickly advance to the next step of drug discovery. Specifically, the DDI program aims to 1) support early stage testing of therapeutic compounds for the treatment of NF and 2) support generation of new in vitro or in vivo model systems for NF.

Max Amount and Period: $85,000 for 1 year (for animal-based preclinical drug testing studies)

$40,000 for 1 year (for cell-based preclinical drug testing studies)

Eligibility: Applicants should have an MD, PhD, or equivalent and have already established all required resources including in vivo and in vitro models in their laboratory. Applicants are required to have a personal ORCID.

Due Date: February 20, 2023 at 4PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

February 20: Outside the Box Grant – Rally Foundation, Kids Join the Fight, and cureMEC

Additional Details

RFP Snapshot: This opportunity is meant to fund investigators in their innovative research strategies that directly address pediatric, adolescent, and young adult brain cancer or myoepithelial carcinoma through a novel idea. These grants are designed to provide seed funding for a new idea that may not have preliminary data but for which a strong case can be made for the potential impact for children battling brain cancer or myoepithelial carcinoma. The application must address the following priority areas related to brain cancer or myoepithelial carcinoma in children, adolescents, and/or young adults: 1) a novel idea for innovative research that could lead to aadvanced studies or clinical trials; 2) treatment approaches that aim to limit the long-term side effects.

Max Amount and Period: $50,000 for 1 year

Eligibility: Applicants may be clinical fellows in pediatric hematology/oncology and/or postdoctoral research fellows conducting pediatric cancer research. The grant is available for MD, DO, PharmD or PhD fellows after the first year of their fellowship. In addition, all academic ranks (Instructor to Professor) and research scientists with MD, DO, PharmD and/or PhD degrees are eligible to apply. Rally defines young investigators as researchers no more than five years post fellowship and independent investigators as researchers who are more than five years post fellowship.  Consortiums of three or more institutions collaborating on a grant-supported research project. Principal investigators do not need to be U.S. citizens or located at a U.S. institution.

Due Date: February 20, 2023 at 4PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

February 20: WUSTL INTERNAL SELECTION: Innovators in Science Award in Cancer Immunology – Early Career Scientist – The New York Academy of Sciences

Additional Details

RFP Snapshot: The Innovators in Science Award recognizes a promising Early-Career Scientist’s contributions to science in the therapeutic areas of Neuroscience, Gastroenterology, Regenerative Medicine, and Oncology, and is intended to support their commitment to innovative research.

Max Amount and Period: $200,000 for 1 year

Eligibility: The nominee must have been engaged in active research for a length of time of 10 years or less since gaining their doctoral degree or equivalent. Candidates near the 10 year limit are preferred. They must also hold a junior level-post-doctoral or faculty position. The candidate must have made impactful research contributions and show exceptional promise for significant future achievement in cancer immunology.

Due Date: February 20, 2023 at 11:59PM CST

Additional Note: Only WUSTL faculty are eligible for this internal selection. WUSTL will nominate ONE candidate for the Early-Career Scientist category.

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

February 20: WUSTL INTERNAL SELECTION: Exceptional Project Grants in Breast Cancer – Breast Cancer Alliance

Additional Details

RFP Snapshot: This award recognizes creative, unique, and innovative breast cancer research. The research project must be directly related to the field of breast cancer. Areas of relevant research may include but are not limited to: diagnosis, etiology, immunology, genetics and epigenetics, therapies, prevention and clinical studies.

Max Amount and Period: $100,000 for 1 year

Eligibility: Breast Cancer Alliance invites clinical doctors and research scientists at any stage of their careers whose primary focus is breast cancer to apply for an Exceptional Project Grant.

Due Date: February 20, 2023 at 11:59PM CST

Additional Note: Only WUSTL faculty are eligible for this internal selection. WUSTL will nominate TWO candidate for the 2024 BCA Exceptional Project Grants.

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

February 20: WUSTL INTERNAL SELECTION: Young Investigator Grants in Breast Cancer – Breast Cancer Alliance

Additional Details

RFP Snapshot: These grants are designed to help advance the careers of young researchers during the first four years of their initial faculty appointment who have not yet received significant external support (NIH R01 or equivalent) but who design and conduct their own independent research projects. The research project must be directly related to the field of breast cancer. Areas of relevant research may include but are not limited to: diagnosis, etiology, immunology, genetics and epigenetics, therapies, prevention and clinical studies.

Max Amount and Period: $125,000 over 2 years

Eligibility: Applicants for the 2024 award must (i) have held a faculty position for no more than four years following completion of their training, as of March 1, 2024; (ii) have not been a principal investigator on an NIH R01 or equivalent national/international non-mentored award; and (iii) dedicate at least 50% of their work effort to research.

Due Date: February 20, 2023 at 11:59PM CST

Additional Note: Only WUSTL faculty are eligible for this internal selection. WUSTL will nominate TWO candidate for the 2024 BCA Young Investigator Project Grants.

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

February 22: BCAN Young Investigator Award – Bladder Cancer Action Network

Additional Details

 

RFP Snapshot: The Young Investigator Award supports the development of research scientists and clinical cancer research investigators who have demonstrated a commitment to improving the understanding and treatment of bladder cancer. Research may be basic, translational, clinical, epidemiologic, bioengineering or any other field.

Max Amount and Period: $50,000 for 1 year

Eligibility: Applicant must be within 6 years of completion of a professional degree or clinical training and must be at the level of Assistant Professor or below at the time of submission.

Due Date: February 22, 2023 at 7PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

February 22: BCAN Patient-Centered Clinical Research Young Investigator Award – Bladder Cancer Action Network

Additional Details

RFP Snapshot: The Patient-Centered Clinical Research Young Investigator Award (PCC-YIA) supports early-career scientists and clinical cancer researchers investigating transformational patient-oriented clinical bladder cancer and/or upper tract urothelial cancer research (e.g. studies of shared decision making, access to care, quality of care, quality of life, health disparities, comparative effectiveness research, patient-centered outcomes research, and survivorship).

Max Amount and Period: $50,000 for 1 year

Eligibility: Applicant must be within 6 years of completion of a professional degree or clinical training (MD, DO, PhD, MD/PhD, MPH, MS, or equivalent) and must be at the level of Assistant Professor or below at the time of submission.

Due Date: February 22, 2023 at 7PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

February 27: LOI: LUNGevity Career Development Awards

Additional Details

RFP Snapshot: This award supports future research leaders who will keep the field of lung cancer research vibrant with new ideas. Projects that will be funded in 2023 are expected to have a direct impact on the early detection of lung cancer or on the outcomes of lung cancer, or to provide a clear conceptual or experimental foundation for the future development of methods for early detection and/or individualized treatment, including through targeted therapy and immunotherapy.

Max Amount and Period: $300,000 over 3 years

Eligibility: Applicants must be within the first five years of their first faculty appointment and have completed training fellowship. Applicant may be at any level of research experience. Applicant may not have a major award, such as a R01, DOD, Merit review, K07, K08, K22, or K23, or any awards valued at $100,000 or more annually. Must be a U.S. citizen or a permanent resident, exchange visitor, or temporary worker, or Canadian or Mexican citizen engaging in professional activities. LUNGevity will grant only one Career Development Award per institution, although more than one applicant from an institution may apply.

Due Date: Letter of Intent Due: February 27, 2023 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

February 27: LOI: LUNGevity VA Research Scholar Award for Translational Research

Additional Details

RFP Snapshot: LUNGevity’s Veterans Affairs Research Scholar Awards for Translational Research program was created to support fellows and junior faculty interested in lung cancer research in the US Department of Veterans Affairs. Research projects are restricted to translational lung cancer research, and the applicant must demonstrate the translational or clinical relevance of the research proposed. The Veterans Affairs Research Scholar Awards are mentored awards; a mentoring plan is part of the required submission.

Max Amount and Period: $100,000 over 2 years

Eligibility: At the beginning of grant term (Nov 2023), the applicant must hold a doctoral degree and be within the first five years of faculty appointment and have completed a training fellowship. Applicant must have a mentoring plan. Applicant may be at any level of research experience. Applicant may not have a major award, such as a R01, DOD, Merit review, K07, K08, K22, or K23, or any awards valued at $100,000 or more annually. Must be a U.S. citizen or a permanent resident, exchange visitor, or temporary worker, or Canadian or Mexican citizen engaging in professional activities.

Due Date: Letter of Intent Due: February 27, 2023 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

February 27: LOI: LUNGevity Health Equity and Inclusiveness Research Fellow Award

Additional Details

RFP Snapshot: This award with one goal: to support fellows interested in lung cancer research and who belong to underrepresented groups in STEM. The translational research projects that will be funded are expected to have a direct impact on the early detection of lung cancer or on the outcomes of lung cancer, or to provide a clear conceptual or experimental foundation for the future development of methods for early detection and/or individualized treatment, including through targeted therapy and immunotherapy.

Max Amount and Period: $100,000 over 2 years

Eligibility: The applicant must be a member of an underrepresented population as defined by the NSF (African American/Black, Hispanic/Latino, Native American/Alaska Native, Native Hawaiian/Other Pacific Islander). At the beginning of grant term (Nov 2023), the applicant must hold a doctoral degree and be within their fellowship (postdoctoral or clinical) period and plan to pursue a career in lung cancer. first five years of faculty appointment and have completed a training fellowship. Applicant must have a mentoring plan. Applicant may not have a major award, such as a R01, DOD, Merit review, K07, K08, K22, or K23. Must be a U.S. citizen or a permanent resident, exchange visitor, or temporary worker, or Canadian or Mexican citizen engaging in professional activities.

Due Date: Letter of Intent Due: February 27, 2023 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

February 27: LOI: LUNGevity Early Detection Award (EDA)

Additional Details

RFP Snapshot: This award funds translational research projects directed at new approaches to improve clinical methods for the detection and diagnosis of primary tumors. Applicants may apply as individuals or in teams. It is strongly encouraged that teams be composed of principal investigators (PIs) from different institutions. All PIs on the team share authority for scientific leadership. The goal is for the project to have a direct impact on early detection and/or diagnosis of lung cancer or a clear conceptual or experimental foundation for the future development of methods for early detection and/or diagnosis.

Max Amount and Period: $600,000 over 2-3 years

Eligibility: At the beginning of grant term (Nov 2023), the applicant must hold a doctoral degree and faculty appointment and have completed a training fellowship. Applicant must be a U.S. citizen or a permanent resident, exchange visitor, or temporary worker, or Canadian or Mexican citizen engaging in professional activities.

Due Date: Letter of Intent Due: February 27, 2023 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

February 27: LOI: Rising Tide/LUNGevity Program to Target Mechanisms of Resistance

Additional Details

RFP Snapshot: The goal of this award is to fund high-impact research that seeks to develop therapeutic strategies targeting shared mechanisms of resistance in oncogene-driven lung adenocarcinoma. Projects funded are expected to further our knowledge of shared mechanisms of resistance across oncogene-driven LUAD and how they can be targeted using novel pharmaceutical agents (monotherapies or combination therapies). We aim to fund those projects that would otherwise not be accomplished without philanthropic support.

Max Amount and Period: $1.5M over 3 years

Eligibility: At least two institutions are required to be involved right from the LOI stage. The Foundation recommends one US and one non-US institution. At the beginning of grant term (Nov 2023), the applicant must hold a doctoral degree and faculty appointment and have completed a training fellowship. Applicant may be at any level of research experience. Applicant must be a U.S. citizen or a permanent resident, exchange visitor, or temporary worker, or Canadian or Mexican citizen engaging in professional activities.

Due Date: Letter of Intent Due: February 27, 2023 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

February 27: LOI: Research Award Program for EGFR-Positive Lung Cancer – EGFR Registers / LUNGevity

Additional Details

RFP Snapshot: The goal of this award is to fund high-impact research that seeks to transform the future for patients diagnosed with EGFR-positive lung cancer by changing EGFR-positive lung cancer into a chronic or curable condition. The research funded through this award is expected to have a direct impact on the outcomes of patients with advanced EGFR-positive lung cancer, but innovative proposals that address other unmet needs in the EGFR-positive lung cancer space are also invited for submission. Applicants are encouraged to propose projects that utilize the resources of the members of EGFR Resisters. Proposed projects must include at least one translational aim that is directly related to improvement of patient outcomes and/or leads to a clinical trial.

Max Amount and Period: $200,000 over 2 years

Eligibility: Applicants must hold a doctoral degree, have completed a postdoctoral training fellowship, and have a faculty appointment. Applicant may be at any level of research experience. Applicant must be a U.S. citizen or a permanent resident, exchange visitor, or temporary worker, or Canadian or Mexican citizen engaging in professional activities.

Due Date: Letter of Intent Due: February 27, 2023 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

February 28: LOI: Career Development Award for Physician Scientists, in Honor of Jose Baselga - AACR-Astra Zeneca

Additional Details

RFP Snapshot: The AACR-AstraZeneca Career Development Award for Physician-Scientists, in Honor of José Baselga has been established to honor the life and legacy of Dr. José Baselga, who was a scientific leader and supportive mentor to an entire generation of physician-scientists. Dr. Baselga’s research focused on novel molecular targeted therapeutics and he played a leading role in the clinical development of multiple cancer drugs. The intent of this program is to encourage and support early-career physician-scientists to conduct research and bolster the development of innovative targeted therapeutics.  The proposed projects may be translational or clinical in nature and focused on all aspects of oncology.

Max Amount and Period: $300,000 for 3 years

Eligibility: Applicants must have a PhD, MD, MD/PhD or equivalent in a related field and not currently be a candidate for a further doctoral degree. Applicants must hold a faculty position with the title of Instructor, Assistant Professor, Research Assistant Professor or the equivalent and have completed their most recent doctoral degree within the past 11 years. Applicants must be able to commit at least 50% of full-time effort in research.

Due Date: Letter of Intent Due: February 28, 2023 at Noon CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

February 28: LOI: New Investigator Research Grants – Leukemia Research Foundation

Additional Details

RFP Snapshot: LRF provides grants for new investigator research projects that will have an impact on leukemia or MDS.

Max Amount and Period: $150,000 for 2 years

Eligibility: Applicants should have an independent faculty-level position and be within seven years of their first position. Applicants need not be US citizens. Applicants with a K08, R00, or R99 are eligible. Fellows are not eligibile to apply. Applicants with any active single grant (or multiple grants added together) that total $175K or greater in total direct costs per year are not eligible.

Due Date: Letter of Intent Due: February 28, 2023 at Noon CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

March Deadlines

March 1: Career Development Awards in Melanoma – Melanoma Research Foundation

Additional Details

RFP Snapshot: Researchers who are beginning a research career focused on melanoma are eligible. This year, in addition to general CDAs, the MRF will again offer the Silverstein Family Research Grant Challenge Women in Science Award/WIS CDA.

Max Amount and Period: $100,000 over 2 years

Eligibility: Applicants must hold a PhD or MD degree or equivalent at the time of grant submission. Applicants may be postdoctoral fellows (with less than 5 years experience), Research Associates/Scientists, Staff Scientists, Instructors, Assistant Professors or equivalent at the time of submission. Applicants are required to have at least one mentor.

NOTE: For the Silverstein Family Research Grant Challenge, applicant must identify as a women.

Due Date: March 1, 2023 at 4pm CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

March 1: Established Investigator Awards in Melanoma – Melanoma Research Foundation

Additional Details

RFP Snapshot: Established melanoma researchers, or senior researchers working in closely related fields who wish to move into melanoma research.

Max Amount and Period: $200,000 over 2 years

Eligibility: Applicants must hold a PhD or MD degree or equivalent at the time of grant submission. Applicants must have a title equivalent to Associate Professor or higher at the time of the grant submission. Both tenured and non-tenured track faculty are encouraged to apply.

Due Date: March 1, 2023 at 4pm CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

March 1: Established Investigator Awards in Melanoma – Melanoma Research Foundation

Additional Details

RFP Snapshot: Investigative team whose research will advance treatment for HLA-A*02:01-negative patients with unresectable or metastatic uveal melanoma. Teams should consist of a PI and at least one co-PI, ideally from different institutions. Teams consisting of both basic scientists and clinicians are encouraged, as is the inclusion of a junior scientist.

Max Amount and Period: $250,000 over 2 years

Eligibility: Applicants must hold a PhD or MD degree or equivalent at the time of grant submission. The applicant must have a title equivalent to Associate Professor or higher at the time of grant submission. Teams are expected to consist of a PI and at least one co-PI, ideally from different institutions.

Due Date: March 1, 2023 at 4pm CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

March 1: LOI: Translational Research Grants – Pediatric Cancer Research Foundation

Additional Details

RFP Snapshot: These grants fund new research protocols and therapies that hold promise for improved outcomes and accelerates cures from the laboratory bench to the bedside of children and teens with high-risk cancers. This Grant is given to single or multi-institutional programs that involve open, cancer clinical trials or consortia, and implement new approaches to therapy.

Max Amount and Period: $150,000 over 2 years

Eligibility: Applicants must be a PhD and/or MD.

Due Date: March 1, 2023 at 6PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

March 1: LOI: Emerging Investigator Fellowship Grants – Pediatric Cancer Research Foundation

Additional Details

RFP Snapshot: These grants are designed to support Post-Doctoral Fellowships and Clinical Investigator training for emerging pediatric cancer researchers to pursue exciting research ideas. These grants encourage and cultivate the best and brightest researchers of the future.

Max Amount and Period: $50,000 for 1 year

 

Eligibility: Applicants must have completed two years of their fellowship or not more than two years as a junior faculty instructor or assistant professor at the start of the award period.

Due Date: March 1, 2023 at 6PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

March 1: LOI: Aging and Cancer Research with the Mark Foundation – Samuel Waxman Research Foundation / The Mark Foundation for Cancer Research

Additional Details

RFP Snapshot: Aging and Cancer projects must include collaborations between two laboratories with different but complementary expertise. Proposals must justify the partnership through synergistic scientific aims. Research topics must support the effort to understanding and prevent the rising of incidence of cancer due to aging.

Max Amount and Period: $500,000 over 3 years

Eligibility: The research team must include a collaboration between two labs with different but complementary expertise. This collaboration is included but not limited to formulation of research plans to augment other SWCRF / Mark Foundation programs, sharing of research materials, reagents, and/or core resources, etc.

Due Date: March 1, 2023 at 4PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

March 1: LOI: Aging and Cancer Research with the Israel Cancer Research Fund – Samuel Waxman Research Foundation / The Israel Cancer Research Fund

Additional Details

RFP Snapshot: Aging and Cancer projects must include collaborations between two laboratories with different but complementary expertise. Proposals must justify the partnership through synergistic scientific aims. Research topics must support the effort to understanding and prevent the rising of incidence of cancer due to aging.

Max Amount and Period: $500,000 over 3 years

Eligibility: The research team must include a collaboration between two labs with different but complementary expertise. This collaboration is included but not limited to formulation of research plans to augment other SWCRF / Mark Foundation programs, sharing of research materials, reagents, and/or core resources, etc.

Due Date: March 1, 2023 at 4PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

March 3: MDS Young Investigator Grant – MDS Foundation

Additional Details

RFP Snapshot: The purpose of this Young Investigator Grant is to provide an early-career investigator the opportunity to initiate, continue or complete a project that focuses on either basic or clinical management into the causation, epidemiology, molecular biology, cytogenetics, morphology, prognosis and treatment of the Myelodysplastic Syndromes or related myeloid neoplasms. The proposal must be for research into MDS or related myeloid neoplasms and may be either translational or basic type investigations. Funding may be used towards salary support, technician support, supplies, equipment, travel, etc. necessary for the pursuit of the recipient’s research project.

Max Amount and Period: $100,000 over 2 years

Eligibility: Applicants must be early in their career – meaning they should have completed their terminal research degree or end of post-graduate clinical training, whichever date is later, within the past 10 years and have NOT previously competed successfully as PD/PI for a substantial independent research award (i.e., NIH, Leukemia Society grant or equivalent).  An additional year may be granted to those who chose to serve as chief residents or for military service.

Due Date: March 3, 2023 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

March 3: LOI: Siteman Investment Program Research Development Awards (SIP RDA) – Siteman Cancer Center

Additional Details

RFP Snapshot: The SIP RDA is designed to award development funding to faculty investigators to support pioneering cancer research and produce data to leverage further external peer-reviewed funding. Available mechanisms include: New and Established Clinical Trials, Phase 0/1 Brain Tumor Center (BTC) Clinical Trials, Pre-R01, Pre-R01 for Collaborations with University of Missouri-Columbia, Team Science, and COE Supplement.

Max Amount and Period: Varies by mechanism from $50,000 to $800,000 over 1-3 years

Eligibility: The PI must have a full-time faculty appointment at Washington University (WU), Saint Louis University (SLU), or the University of Missouri-Columbia (MU). Faculty from Saint Louis University and University of Missouri-Columbia are required to have a WU Siteman Cancer Center faculty member as co-PI. The contact PI submitting the application must be a Siteman Cancer Center member.

Due Date: Letter of Intent Due: March 3, 2023 at 4pm CST

March 6: COG Hematopoietic Malignancies Translational Pilot Studies – Children’s Oncology Group

Additional Details

RFP Snapshot: The purpose of the HM-ITSC is to foster the development and implementation of translational research studies that will support future clinical trials in hematopoietic malignancies. HM-TPSP projects are those with pre-existing data to support the clinical relevance of this work, but that require additional data to validate existing findings, define the prevalence in a larger study cohort to establish statistical significance, define risk class or generate similar data to facilitate rapid incorporation of data in the next clinical trial.

Max Amount and Period: $60,000 for 1 year

 

Eligibility: HM-ITSC leadership invites interested COG members to submit research proposals. Non-members at COG institutions are also invited to apply, but must become a COG individual member if awarded.

Due Date: March 6, 2023 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal

March 10: LOI: PCF Team Science Challenge Awards for Metastatic, Lethal Prostate Cancer – Prostate Cancer Foundation

Additional Details

RFP Snapshot: This award is meant to fund investigations of metastatic, lethal prostate cancer. These awards will be funded depending on the level of innovation in applications received. PCF seeks high-risk, currently unfunded projects from academic institutions around the world. We especially encourage applications on prostate cancer disparity research that will help to define the origins of differential outcome for prostate cancer patients in men of under-represented populations, including those focusing on biology or health care access policy. We also seek applications conducting research in VA hospitals where research directly affects veterans with advanced prostate cancer. Clinical trial costs are not allowed.

Max Amount and Period: $1M over 2 years

Eligibility: The award team should be composed of at least 3 investigators capable of providing unique expertise and may be assembled from one, or several, institutions. Each team must have at least one young investigator (postdoc, instructor, research associate, assistant professor within six-years following degree).

Due Date: Letter of Intent Due: March 10, 2023 at 2PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

March 13: Frist Family Endowed Young Investigator Award in Mantle Cell Lymphoma in Honor of Howard A. Burris, III, MD - The ASCO Foundation / Conquer Cancer

Additional Details

RFP Snapshot: This award provides funding to promising investigators to encourage and promote quality research in clinical oncology with a focus on mantle cell lymphoma. The purpose of this endowed YIA award is to fund physicians during the transition from a fellowship program to a faculty appointment. This is a mentored award and the research project is conducted under the guidance of a scientific mentor. Applications are accepted from U.S. and international applicants.

Max Amount and Period: $50,000 for 1 year

Eligibility: Applicants must be physicians (MD, DO, or international equivalent) working in any country and currently in the last two years of their final oncology subspecialty training AND within 10 years of obtaining their medical degree at the time of grant submission. Applicants must also be planning an investigative career in clinical oncology with a focus on mantle cell lymphoma and be able to commit at least 60% of full-time effort to total research. Must be an ASCO member.

Due Date: March 13, 2023 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

March 13: Dr. Jose Leis Endowed Young Investigator Award in Chronic Lymphocytic Leukemia - The ASCO Foundation / Conquer Cancer

Additional Details

RFP Snapshot: This award provides funding to promising investigators to encourage and promote quality research in clinical oncology with a focus on chronic lymphocytic leukemia. The purpose of this award is to fund physicians during the transition from a fellowship program to a faculty appointment. This is a mentored award and the research project is conducted under the guidance of a scientific mentor. Applications are accepted from U.S. and international applicants.

Max Amount and Period: $50,000 for 1 year

Eligibility: Applicants must be physicians (MD, DO, or international equivalent) working in any country and currently in the last two years of their final oncology subspecialty training AND within 10 years of obtaining their medical degree at the time of grant submission. Applicants must also be planning an investigative career in clinical oncology with a focus on chronic lymphocytic leukemia and be able to commit at least 60% of full-time effort to total research. Must be an ASCO member.

Due Date: March 13, 2023 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

March 13: Career Development Award (CDA) for Diversity and Inclusion in Breast Cancer Research – The ASCO Foundation – Conquer Cancer

Additional Details

RFP Snapshot: This CDA is designed with the primary goal of increasing diversity in the breast cancer research workforce. This CDA will provide funding to clinical investigators who identify as members of racial and/or ethnic groups traditionally excluded in academic medicine and biomedical research who have received their initial faculty appointment. This is a mentored award and the research project must be conducted under the guidance of a scientific mentor.

Max Amount and Period: $200,000 over 3 years

Eligibility: Applicants must have received their initial faculty appointment (within first to third year) and identify as members of racial and/or ethnic groups traditionally excluded in academic medicine and biomedical research (according to the AAMC definition – includes but not limited to: American Indian/Alaska Native, Black/African American, Hispanic/Latino, and Native Hawaiian/Other Pacific Islander). Must be able to commit more than 50% of full-time effort to total research. Must be an ASCO member or have submitted a membership with the grant application.

Due Date: March 13, 2023 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

March 13: Young Investigator Award (YIA) for Diversity and Inclusion in Breast Cancer Research – The ASCO Foundation – Conquer Cancer

Additional Details

RFP Snapshot: This YIA is designed with the primary goal of increasing diversity in the oncology workforce and breast cancer research. The YIA will provide funding to promising investigators who identify as members of racial and/or ethnic groups traditionally excluded in academic medicine and biomedical research. The purpose of this award is to fund physicians during the transition from a fellowship program to a faculty appointment as they seek to build a career in clinical breast cancer research.

Max Amount and Period: $50,000 for 1 year

Eligibility: Applicants must be a physician currently in the last two years of their final oncology subspecialty training and within 10 years of obtaining their medical degree. Applicants must identify as members of racial and/or ethnic groups traditionally excluded in academic medicine and biomedical research (according to the AAMC definition – includes but not limited to: American Indian/Alaska Native, Black/African American, Hispanic/Latino, and Native Hawaiian/Other Pacific Islander). Must be able to commit more than 60% of full-time effort to total research. Must be an ASCO member or have submitted a membership with the grant application.

Due Date: March 13, 2023 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

March 15: Damon Runyon Fellowship Award – Damon Runyon Cancer Research Foundation

Additional Details

RFP Snapshot: Applicants must apply for the fellowship under the guidance of a Sponsor—a scientist (tenured, tenure-track or equivalent position) capable of providing mentorship to the Fellow. In addition to aiding in the planning, execution and supervision of the proposed research, the Sponsor’s role is to foster the development of the Fellow’s overall knowledge, technical and analytical skills, and capacity for scientific inquiry.

Max Amount and Period: $260,000 over 4 years

Eligibility: Applicants must have completed one or more of the following degrees or its equivalent: MD, PhD, MD/PhD, DDS, DVM, DO. Applicants holding NIH K awards cannot apply, except for holders of the K12 awards (but the K12 funding must be turned back if a Fellowship is awarded). Awardees are expected to devote between 80% and 100% of their time to Damon Runyon-supported research (see RFA for specifics).

Due Date: March 15, 2023 at 3PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

March 15: Distinguished Scientist Award – The Sontag Foundation

Additional Details

RFP Snapshot: The Sontag Foundation is investing in the scientific careers of young brain cancer investigators pursuing high-risk projects at a critical stage in their research. This award will not support clinical trials.

Max Amount and Period: $750,000 over 5 years

Eligibility: Applicants must have received their first independent faculty appointment no earlier than March 1, 2018 and no later than January 1, 2023 and must be on the tenure track. Applicant’s career track and proposed research should demonstrate outstanding promise as contributors to science relevant to brain cancer research (basic science & related fields encouraged to apply).

Due Date: March 15, 2023 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

March 15: LOI: Big Ideas: A Data-Driven Innovation Competition – Washington University School of Medicine

Additional Details

RFP Snapshot: The intent of the Big Ideas competition is to support innovative projects that are clinically relevant, rigorously evaluated and operationally sustainable. Applications should explain how their proposed project speaks to these characteristics. Preference is given to projects that involve collaboration across BJC HealthCare and WUSM.

Max Amount and Period: $50,000 for 1 year

Eligibility: Primary investigators/project leads may hold only one innovation award at a time and total awarded funds may not exceed $50,000 within a 12-month period (PIs may serve as team members on multiple teams). Proposals should include at least three members in good standing in order to be considered. An example of a successful team could be: a clinician, a research investigator, and an operational champion. For research fellows or trainees, the mentor (faculty member) must submit the application as the primary investigator. Please describe within the application the trainee-mentor circumstance.

Due Date: Letter of Intent Due: March 13, 2023 at 10:59PM CST

Additional Note: Previous cancer-related awardees include: Chet Hammill (2019), Patrick Lyons (2020), Camilo Molina (2022), Karla Washington (2021), Tinayu Zhao (2022).

March 20: LOI: CTF Clinical Research Award – Children’s Tumor Foundation

Additional Details

RFP Snapshot: The purpose of the CRA is to advance effective clinical therapies for NF by supporting early-stage investigations of broad-thinking, novel ideas involving candidate therapeutics, neurocognitive or psychosocial interventions, and clinical-trial-enabling studies. Examples of areas of interest include, but are not limited to: pilot clinical trials or studies adjunct to an ongoing clinical trial, Biomarker studies (e.g. molecular, imaging, or genetic biomarkers) that may inform or accelerate a clinical trial or the development of diagnostics, etc.

Max Amount and Period: $150,000 over 2 years

Eligibility: Applicants should have an MD, PhD, or equivalent. Applicants are required to have a personal ORCID.

Due Date: Letter of Inquiry: March 20, 2023 at 4PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

April Deadlines

April 3: ASTRO-ACS Clinician Scientist Development Grant (CSDG) – ASTRO/American Cancer Society

Additional Details

RFP Snapshot: The Clinician Scientist Development Grant (CSDG) supports junior faculty members in becoming independent investigators as clinician scientists. This grant is designed for people trained primarily as clinicians who want to maintain clinical practice and conduct cancer research. Specifically for this RFA in partnership with ASTRO, the applicant must be in the radiation oncology field.

Max Amount and Period: $405,000 to $675,000 over 3 to 5 years

Eligibility: Applicants must have a clinical doctoral degree with an active license to provide clinincal care and be within the first 6 years of starting a full-time faculty appointment. They must have had LESS than 3 years of mentored post-doctoral research training or experience. They must not have had an individual NIH K-type grant nor held an R-level grant as a PI.

Due Date: April 3, 2023 at 10:59PM CST

ACS Grants Workshop Webinar: The American Cancer Society is conducting a 90-minute virtual Extramural Discovery Science Grants workshop on February 22 from 1PM to 2:30PM CST. Be sure to register in advance for this meeting!

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

April 3: AHEAD (Advancing Health Equity and Addressing Cancer Disparities) Discovery Boost Grants - American Cancer Society

Additional Details

RFP Snapshot: This opportunity is intended to fund pilot, first-in-field, innovative strategies that increase quality cancer screening, clinical trials—and cancer care closer to home. It will fund exploratory, novel research studies that seek to improve access to quality cancer screening and/or cancer care by bringing technologies to individuals rather than requiring travel to health care facilities.

Max Amount and Period: $250,000 over 2 years

Eligibility: Independent investigators at any career stage are eligible to apply. Investigators must have a doctorate degree, (MD, PhD, DVM, or equivalent), and have a full-time faculty position or equivalent at a college, university, medical school, or other fiscally responsible, not-for-profit research organization within the United States (US) or its territories. There are no citizenship restrictions.

Due Date: April 3, 2023 at 10:59PM CST

ACS Grants Workshop Webinar: The American Cancer Society is conducting a 90-minute virtual Extramural Discovery Science Grants workshop on February 22 from 1PM to 2:30PM CST. Be sure to register in advance for this meeting!

Application Assistance: Washington University faculty may reach out to Sarah Van Vickle-Chavez in Public Health Sciences at sarahv@wustl.edu with any questions and for assistance with the proposal, including gathering pertinent catchment statistics.